June X. Nguyen, associate director of business development at Eisai Inc., spoke about the ins and outs of
integration after a merger.
At The Deal's recent Healthcare Dealmaking Symposium, she talked about how the big Japanese pharmaceutical firm is integrating a couple of important biotech acquisitions in the U.S.: MGI Pharma, which Eisai
bought for $3.9 billion in December, and Morphotek, which it
bought in March 2007 for $325 million.
- George WhiteSee more video from Healthcare Dealmaking Symposium
Join Corporate Dealmaker's LinkedIn forum
Juergen Lasowski
And the winners are...
